Neoadjuvant Sequential Docetaxel Followed by High-Dose Epirubicin in Combination With Cyclophosphamide Administered Concurrently With Trastuzumab. The DECT Trial

Laura Pizzuti, Maddalena Barba, Diana Giannarelli, Domenico Sergi, Claudio Botti, Paolo Marchetti, Michele Anzà, Marcello Maugeri-Saccà, Clara Natoli, Simona Di Filippo, Teresa Catenaro, Federica Tomao, Antonella Amodio, Silvia Carpano, Letizia Perracchio, Marcella Mottolese, Luigi Di Lauro, Giuseppe Sanguineti, Anna Di Benedetto, Antonio GiordanoPatrizia Vici

Research output: Contribution to journalArticlepeer-review

Fingerprint

Dive into the research topics of 'Neoadjuvant Sequential Docetaxel Followed by High-Dose Epirubicin in Combination With Cyclophosphamide Administered Concurrently With Trastuzumab. The DECT Trial'. Together they form a unique fingerprint.

Mathematics

Medicine & Life Sciences

Chemical Compounds

Engineering & Materials Science

Earth & Environmental Sciences